Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Joseph H Wender

Director at Ionis Pharmaceuticals Inc (IONS)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $5.4M

Reported trades

Filed Stock Type Shares Price Value Since
Dec 3SEC IONSIonis Pharmaceuticals Inc Sell Plan 20,57143,464 held (−32%) $80.67 $1.7M -43.9%
Dec 3SEC IONSIonis Pharmaceuticals Inc Sell Plan 7,42936,035 held (−17%) $81.23 $603K -44.3%
Nov 3SEC IONSIonis Pharmaceuticals Inc Sell Plan 2,48489,551 held (−3%) $72.19 $179K -37.3%
Nov 3SEC IONSIonis Pharmaceuticals Inc Sell Plan 8,34181,210 held (−9%) $73.16 $610K -38.1%
Nov 3SEC IONSIonis Pharmaceuticals Inc Sell Plan 5,97575,235 held (−7%) $73.85 $441K -38.7%
Nov 3SEC IONSIonis Pharmaceuticals Inc Sell Plan 11,20064,035 held (−15%) $75.16 $842K -39.8%
Oct 2SEC IONSIonis Pharmaceuticals Inc Sell Plan 16,80092,035 held (−15%) $65.50 $1.1M -30.9%
  • Sell

    Director Joseph H Wender sold $1.7M of IONS at $80.67 — cuts the stake by 32%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Joseph H Wender sold $603K of IONS at $81.23 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Joseph H Wender sold $179K of IONS at $72.19 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Joseph H Wender sold $610K of IONS at $73.16 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Joseph H Wender sold $441K of IONS at $73.85 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Joseph H Wender sold $842K of IONS at $75.16 — pre-scheduled 10b5-1 plan sale.